Biotech gets federal cybersecurity shield—and a seat at the table
S. 5502 — Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act · Filed by Maggie Hassan (D-NH) · 1 cosponsor · Introduced Sep 24, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill designates biotechnology and biomanufacturing infrastructure as critical infrastructure under federal cybersecurity protection, assigning CISA (the Cybersecurity and Infrastructure Security Agency) to oversee its security. It requires CISA to identify stakeholders, coordinate with industry groups and information-sharing organizations, and submit work plans and progress reports to Congress on protecting this sector.
Why we flagged it
The bill's operative mechanism is to formally designate biotechnology and biomanufacturing as critical infrastructure sectors under federal cybersecurity oversight, expanding CISA's mandate and coordinating industry protection efforts.
What the text implies
- CISA gains new staffing and resource demands to manage a sector with no pre-existing Sector-Specific Agency, potentially straining agency capacity.
- Industry information-sharing organizations (BIO-ISAC, H-ISAC) become formal partners in federal threat intelligence, raising questions about data governance and private-sector access to classified threat information.
- The bill does not specify whether biotech firms must comply with new security standards or reporting requirements, leaving implementation details to CISA discretion.
- Designation as critical infrastructure may trigger additional regulatory scrutiny and compliance costs for smaller biotech firms, creating a potential barrier to entry.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Biotechnology and biomanufacturing underpin pharmaceuticals, vaccines, and medical devices critical to public health. Designating this sector as critical infrastructure and assigning CISA to coordinate cybersecurity protections reduces the risk of supply disruptions from cyberattacks, which could harm patients and public health. The bill creates no new restrictions on citizens and imposes no costs on the public.
Who stands to gain
- biotechnology companies
- biomanufacturing firms
- information-sharing organizations (BIO-ISAC, H-ISAC)
- cybersecurity service providers serving the biotech sector
Named in the bill
CISA (Cybersecurity and Infrastructure Security Agency), Department of Homeland Security, BIO-ISAC (Biotechnology Information Sharing and Analysis Center), H-ISAC (Healthcare Information Sharing and Analysis Center), Sector-Specific Agencies, Committee on Homeland Security (House), Committee on Homeland Security and Governmental Affairs (Senate)
Where it stands
1 cosponsor: 1 Republicans.
- Sep 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
- Sep 24, 2026 — Referred to Senate Committee on Homeland Security and Governmental Affairs · Congress.gov: “Read twice and referred to the Committee on Homeland Security and Governmental Affairs”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (4,501 characters) on Sep 30, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Biotech gets federal cybersecurity shield—and a seat at the table” QuorumCivic. https://share.quorumcivic.app/bill/119/s5502 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.